Drug for Duchenne Muscular Dystrophy Sails Through FDA Approval, Questioned by Shareholders
Duchenne muscular dystrophy (DMD) is a particularly cruel genetic disease. It most commonly affects boys, who by the age of three, begin to experience muscle weakness in the legs, hips…